1. Home
  2. CTXR vs OESX Comparison

CTXR vs OESX Comparison

Compare CTXR & OESX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTXR
  • OESX
  • Stock Information
  • Founded
  • CTXR 2007
  • OESX 1996
  • Country
  • CTXR United States
  • OESX United States
  • Employees
  • CTXR N/A
  • OESX N/A
  • Industry
  • CTXR Biotechnology: Pharmaceutical Preparations
  • OESX Building Products
  • Sector
  • CTXR Health Care
  • OESX Consumer Discretionary
  • Exchange
  • CTXR Nasdaq
  • OESX Nasdaq
  • Market Cap
  • CTXR 20.8M
  • OESX 21.6M
  • IPO Year
  • CTXR N/A
  • OESX 2007
  • Fundamental
  • Price
  • CTXR $1.13
  • OESX $9.32
  • Analyst Decision
  • CTXR Strong Buy
  • OESX Strong Buy
  • Analyst Count
  • CTXR 3
  • OESX 2
  • Target Price
  • CTXR $53.00
  • OESX $17.50
  • AVG Volume (30 Days)
  • CTXR 473.1K
  • OESX 21.4K
  • Earning Date
  • CTXR 08-12-2025
  • OESX 11-05-2025
  • Dividend Yield
  • CTXR N/A
  • OESX N/A
  • EPS Growth
  • CTXR N/A
  • OESX N/A
  • EPS
  • CTXR N/A
  • OESX N/A
  • Revenue
  • CTXR N/A
  • OESX $79,389,000.00
  • Revenue This Year
  • CTXR N/A
  • OESX $6.63
  • Revenue Next Year
  • CTXR $851.67
  • OESX $13.51
  • P/E Ratio
  • CTXR N/A
  • OESX N/A
  • Revenue Growth
  • CTXR N/A
  • OESX N/A
  • 52 Week Low
  • CTXR $0.65
  • OESX $5.50
  • 52 Week High
  • CTXR $15.25
  • OESX $10.35
  • Technical
  • Relative Strength Index (RSI)
  • CTXR 39.44
  • OESX 79.42
  • Support Level
  • CTXR $1.10
  • OESX $7.18
  • Resistance Level
  • CTXR $1.25
  • OESX $9.09
  • Average True Range (ATR)
  • CTXR 0.09
  • OESX 0.48
  • MACD
  • CTXR -0.01
  • OESX 0.22
  • Stochastic Oscillator
  • CTXR 8.49
  • OESX 99.40

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

About OESX Orion Energy Systems Inc.

Orion Energy Systems Inc is engaged in light-emitting diode lighting systems, wireless Internet of Things-enabled control solutions, project engineering, energy project management design, maintenance services, and turnkey electric vehicle charging stations and related installation services to commercial and industrial businesses, and federal and local governments, predominantly in North America. The group has three segments: the Orion lighting segment, the Orion maintenance segment, and the Orion electric vehicle charging segment. It generates the majority of its revenue from the Orion lighting segment, which develops and sells lighting products and provides construction and engineering services for Orion's commercial lighting and energy management systems.

Share on Social Networks: